This HTML5 document contains 222 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://dx.doi.org/10.1084/
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q36371262
rdf:type
wikibase:Item
schema:description
artikull shkencor articolo scientifico tudományos cikk 2002年學術文章 scientific article article scientific บทความทางวิทยาศาสตร์ bilimsel makale наукова стаття, опублікована у вересні 2002 artigo científico wetenschappelijk artikel 2002年学术文章 научна статия artigo científico (publicado na 2002) مقالة علمية نشرت في سبتمبر 2002 2002年學術文章 article científic επιστημονικό άρθρο 2002년 논문 мақолаи илмӣ vitenskapelig artikkel 2002年學術文章 artículo científico publicado en 2002 bài báo khoa học artikulong pang-agham wissenschaftlicher Artikel 2002年学术文章 vitskapeleg artikkel naučni članak vědecký článek مقالهٔ علمی სამეცნიერო სტატია artigo científico (publicado na 2002) artykuł naukowy 2002年學術文章 2002年學術文章 научная статья videnskabelig artikel (udgivet 2002) سائنسی مضمون 2002年学术文章 מאמר מדעי scienca artikolo vedecký článok ২০০২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ articol științific 2002年の論文 научни чланак 2002年學術文章 artículu científicu espublizáu en 2002 научни чланак teaduslik artikkel գիտական հոդված 2002 nî lūn-bûn tieteellinen artikkeli mokslinis straipsnis vetenskaplig artikel 2002年学术文章 article scientifique (publié 2002) 2002年学术文章 мақолаи илмӣ
p:P577
wds:Q36371262-0F19BEBF-94DD-4ADD-9C78-F2623F832F2B
wdt:P577
2002-09-01T00:00:00Z
p:P407
wds:Q36371262-D0B7B7D5-40A4-4153-95DB-6A56F47207CD
wdt:P407
wd:Q1860
p:P2860
wds:Q36371262-AC094DDC-03B8-45F5-9AB6-C2046AA0FC18 wds:Q36371262-B387A946-8256-46F1-92D7-1307D3904AD2 wds:Q36371262-B5F41836-2A3C-40EE-A5E8-4B828D57A27E wds:Q36371262-BA4A11F0-9855-4AA8-842A-8FDE3351F17C wds:Q36371262-BAB2A30D-76A3-41B7-B356-72508BD76D49 wds:Q36371262-BC5EE7BD-8328-4D22-A698-51BF6DC2BBD5 wds:Q36371262-C8BB8399-F12C-4675-A305-141B31F74C49 wds:Q36371262-0628B404-1043-419A-822F-F557DB0A4B67 wds:Q36371262-CA6D3D13-E418-48E4-BE88-B31EE56378AE wds:Q36371262-CA8A0A93-E0C2-47B0-A702-792EC614FD3B wds:Q36371262-125A6067-4523-430E-8B41-0C4FE2C45F25 wds:Q36371262-1A0DA101-A470-47E7-9694-7D7985AAD3BF wds:Q36371262-DA3606A0-8FF5-4062-9705-F108C5DFC6F3 wds:Q36371262-DA3C0086-8F7E-45BD-9C76-C9766090E9E5 wds:Q36371262-1E999267-05AB-4A7E-8070-6223029EF3A1 wds:Q36371262-DD53B305-538E-4886-A310-73DEFB2604E6 wds:Q36371262-273C5C85-99A6-4537-A082-CB09047FF582 wds:Q36371262-DE4EDCC2-662D-424B-BEB6-1FD68889F120 wds:Q36371262-2F5539EA-34E2-43DA-BDAC-DEF5D735EE09 wds:Q36371262-E363BAA6-9904-4548-8C9E-9B7CB238284E wds:Q36371262-3A79887F-D19C-46F8-A60B-F168C1D177F8 wds:Q36371262-E5412D16-67DB-4E9D-800D-6D1D166124CF wds:Q36371262-3B2349B4-6A6B-4C15-B293-36EEE93046EC wds:Q36371262-E5EC94CA-6DDB-4D1E-9AFD-5A208F63D056 wds:Q36371262-3C701FE8-ABB9-4396-BEC7-1DA0D64D08A0 wds:Q36371262-3D5EBDA9-72B8-441D-AD0C-9EFB42A94052 wds:Q36371262-E7220B78-273E-4146-9793-701EDFE6E757 wds:Q36371262-3DF61013-3041-41A5-AB5D-AAB7EE1D7E10 wds:Q36371262-41B8AF40-F4F6-43AC-B907-BBDA90B3B760 wds:Q36371262-EAB383DA-6752-4053-A5E5-4FD36D1BAF0D wds:Q36371262-F2AE7893-9220-47D6-A25F-CBF76350B628 wds:Q36371262-4ECCF3BF-A648-4E01-973E-96E2B5B6D259 wds:Q36371262-F64E1B6A-D4D4-47D9-8DBB-A82605D43C79 wds:Q36371262-5911AE42-D55B-4A8C-8646-950D573BC9A2 wds:Q36371262-F66DA8F1-7D67-4367-94A5-B8021B8F5FC8 wds:Q36371262-5ABCB029-4F67-4F69-9330-84532B401432 wds:Q36371262-67E1103C-3C46-41E3-8FCF-72281F073659 wds:Q36371262-6A5D4C48-D985-4D0E-9886-BAD1F7B0EA7B wds:Q36371262-7B0883D3-B282-46DD-BD54-4BCF1DED1F5F wds:Q36371262-7B46D2F1-9FE1-4E90-A834-1085D03A6AE5 wds:Q36371262-80FEF04F-27CF-46A6-B84F-79CAD638C329 wds:Q36371262-843059FD-B798-45ED-A3B2-73C6D402ACB2 wds:Q36371262-8AE5C546-037E-4984-A048-082BE9865765 wds:Q36371262-925E6026-562A-49B4-87E2-53B4120407A0 wds:Q36371262-9313389F-4B26-401E-9245-A9D9CDA4FB7E wds:Q36371262-957730F3-5BDF-4166-880F-978C288F7798 wds:Q36371262-99021A24-6F4F-4D6B-963F-88DF3AF8EEBE wds:Q36371262-9B6CDF85-89BA-459B-9990-4C18F094E9B6 wds:Q36371262-9E2F143C-1CFF-492A-B6EE-1DC4EB2A1D94 wds:Q36371262-A104679E-E541-467C-9FF7-86C085526AC8 wds:Q36371262-A862A5C7-3B5D-4F78-BFA5-26226D54B3A2 wds:Q36371262-AA0DCAF2-712B-42CC-9DC5-D6F9C9860E01
wdt:P2860
wd:Q45869654 wd:Q52539892 wd:Q33784288 wd:Q40890338 wd:Q77652479 wd:Q42850939 wd:Q34398736 wd:Q28238886 wd:Q74129831 wd:Q35081587 wd:Q24321792 wd:Q28593600 wd:Q44654746 wd:Q33964642 wd:Q40727529 wd:Q43956050 wd:Q28209860 wd:Q28245526 wd:Q35746804 wd:Q24532314 wd:Q41050928 wd:Q71139703 wd:Q39433111 wd:Q34398732 wd:Q35746429 wd:Q39714957 wd:Q73849053 wd:Q40827632 wd:Q28200072 wd:Q37625629 wd:Q28200101 wd:Q44166149 wd:Q42476595 wd:Q22254202 wd:Q33802149 wd:Q29547485 wd:Q57382204 wd:Q40845503 wd:Q73025820 wd:Q45884147 wd:Q56825474 wd:Q73715128 wd:Q28588628 wd:Q73820249 wd:Q28191040 wd:Q45871293 wd:Q34503413 wd:Q68066299 wd:Q40721888 wd:Q47778077 wd:Q41757138 wd:Q28513759
p:P2093
wds:Q36371262-84681BB7-35E6-4E84-800A-17BB0B48EDA8 wds:Q36371262-862C34C8-7E97-4D6F-944B-A70700D7CD2F
wdt:P2093
Tanja Veikkola Hansruedi Bueler
rdfs:label
Lymphangiogenic gene therapy with minimal blood vascular side effects Lymphangiogenic gene therapy with minimal blood vascular side effects Lymphangiogenic gene therapy with minimal blood vascular side effects
skos:prefLabel
Lymphangiogenic gene therapy with minimal blood vascular side effects Lymphangiogenic gene therapy with minimal blood vascular side effects Lymphangiogenic gene therapy with minimal blood vascular side effects
schema:name
Lymphangiogenic gene therapy with minimal blood vascular side effects Lymphangiogenic gene therapy with minimal blood vascular side effects Lymphangiogenic gene therapy with minimal blood vascular side effects
p:P50
wds:Q36371262-D6738C9D-FA6F-43CD-B3F0-C29F186B71C2 wds:Q36371262-128423CF-4904-4A06-AAD6-1F97B9FE4F99 wds:Q36371262-1D9CD568-7CBA-47A7-8CCA-C7D172670A69 wds:Q36371262-8D48E1C1-F0BF-4448-A082-4DE29A4B3111 wds:Q36371262-891DD2E0-143B-4455-B9A6-BAAD2605CA1E wds:Q36371262-5F1F1195-C227-4983-A075-7E9127945F53 wds:Q36371262-481276C1-E5AA-42DD-B869-5BC0C356E02A
wdt:P50
wd:Q74796250 wd:Q125255289 wd:Q11893052 wd:Q125253656 wd:Q125253795 wd:Q6370341 wd:Q125257675
p:P1476
wds:Q36371262-6F96695F-C231-44C7-AB68-57C3F5A93090
wdt:P1476
Lymphangiogenic gene therapy with minimal blood vascular side effects
p:P304
wds:Q36371262-E9638603-3A47-4FB9-9867-8DE4ADBD2A8C
wdt:P304
719-730
p:P31
wds:Q36371262-BE473D94-D7C8-490A-A393-4463942CB0D9
wdt:P31
wd:Q13442814
p:P921
wds:Q36371262-5B10F30C-4862-4FF1-B517-1B24ABC83792
wdt:P921
wd:Q213901
p:P698
wds:Q36371262-DE575263-3047-44D0-8CA7-E4365936E764
wdtn:P698
n12:12235206
wdt:P698
12235206
p:P1433
wds:Q36371262-F977F699-92F2-45AA-8755-D1F39759D7C3
wdt:P1433
wd:Q3186912
p:P433
wds:Q36371262-92D22BE3-5D6D-4D69-8B24-4AC3CD7C7DD1
p:P478
wds:Q36371262-AE6F5688-F872-437B-9710-5C2D85202573
wdt:P433
6
wdt:P478
196
p:P356
wds:Q36371262-826060FD-10D6-4120-B76C-71D3811D1D14
wdtn:P356
n10:JEM.20020587
wdt:P356
10.1084/JEM.20020587
p:P8608
wds:Q36371262-385F14EA-0386-47CA-B628-90506E005BAA
wdt:P8608
release_so45axfx3zg33iotz5rgr2a3ha
p:P5875
wds:Q36371262-99414294-0907-469C-AD90-62D8694CD5C5
wdt:P5875
11155889
p:P932
wds:Q36371262-002F57D9-71D8-4EEB-89F7-CE9E51B9BE77
wdt:P932
2194057